Initial public offerings scheduled to debut next week

NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.

Week of Sept. 9

Bicara Therapeutics – Boston, 11.8 million shares, priced at $16-$18, managed by Morgan Stanley TD Cowen. Proposed Nasdaq symbol BCAX. Business: Phase 1 biotech developing a bifunctional antibody to target solid tumors.

Zenas BioPharma – Waltham, Mass., 11.8 million shares, priced at $16-$18, managed by Morgan Stanley Jefferies. Proposed Nasdaq symbol ZBIO. Business: Phase 3 biotech developing therapies for autoimmune and inflammatory diseases.

Cuprina Holdings – Singapore, 3.8 million shares, priced at $4-$4.50, managed by Network 1. Proposed Nasdaq symbol CUPR. Business: Singapore-based provider of skincare and chronic wound care products.

Trident Digital Tech – Singapore, 1.8 million shares, priced at $5-$7, managed by WallachBeth Revere Sec.. Proposed Nasdaq symbol TDTH. Business: Provides business consulting, marketing, and IT services to SMEs in Singapore.

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up